PAI-1 4G/5G Polymorphism is Associated with Brain Vessel Reocclusion After Successful Fibrinolytic Therapy in Ischemic Stroke Patients

REFERENCES

• Adams, H. P., Bendixen, B. H., Kappelle, L. J., Biller, J., Love, B. B., Gordon, D. L., (1993). Classification of subtype of acute ischemic stroke: Definitions for use in a multicenter clinical trial. Stroke, 24, 35–41.
   PubMed Web of Science ®Google Scholar
• Alexandrov, A. V., Demchuk, A. M., Felberg, R. A., Christou, I., Barber, P. A., Burgin, W. S., (2000). High rate of complete recanalization and dramatic clinical recovery during tPA infusion when continuous monitored with 2-MHz transcranial Doppler monitoring. Stroke, 31, 610–614.
   PubMed Web of Science ®Google Scholar
• Brott, T. G., Haley, E. C., Levy, D. E., Barsan, W., Broderick, J., Sheppard, G. L., (1992). Urgent therapy for stroke, part I: Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke, 23, 632–640.
   PubMed Web of Science ®Google Scholar
• Burgin, W. S., Malkoff, M., Demchuk, A. M., Felberg, R. A., Christou, I., Grota, J. C., (2000). Transcranial Doppler ultrasound criteria for recanalization after thrombolysis for middle cerebral artery stroke. Stroke, 31, 1128–1132.
   PubMed Web of Science ®Google Scholar
• Dawson, S. J., Wiman, B., Hamsten, A., Green, F., Humphries, S., & Henney, A. M. (1993). The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. The Journal of Biological Chemistry, 268, 10739–10745.
   PubMed Web of Science ®Google Scholar
• Demchuk, A. M., Burgin, W. S., Christou, I., Felberg, R. A., Barber, P. A., Hill, M. D., (2001). Thrombolysis in Brain Ischemia (TIBI) transcranial Doppler flow grades predict clinical severity, early recovery, and mortality in patients treated with intravenous tissue plasminogen activator. Stroke, 32, 89–93.
   PubMed Web of Science ®Google Scholar
• Eriksson, P., Kallin, B., van't Hooft, F. M., Bavenholm, P., & Hamsten, A. (1995) Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proceedings of the National Academy of Sciences of the United States of America, 92, 1851–1855.
   PubMed Web of Science ®Google Scholar
• Fernandez-Cadenas, I., Alvarez-Sabin, J., Ribo, M., Rubiera, M., Mendioroz, M., Molina, C. A., (2007). Influence of thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 gene polymorphisms on tissue-type plasminogen activator-induced recanalization in ischemic stroke patients. Journal of Thrombosis and Haemostasis, 5, 1862–1868.
   PubMedGoogle Scholar
• Fernandez-Cadenas, I., Molina, C. A., Alvarez-Sabin, J., Ribo, M., Penalba, A., Ortega-Torres, L., (2006). ACE gene polymorphisms influence t-PA-induced brain vessel reopening following ischemic stroke. Neuroscience Letters, 398, 167–171.
   PubMedGoogle Scholar
• Gonzalez-Conejero, R., Fernandez-Cadenas, I., Iniesta, J. A., Marti-Fabregas, J., Obach, V., Alvarez-Sabin, J., (2006). Proyecto Ictus Research Group Role of fibrinogen levels and factor XIII V34L polymorphism in thrombolytic therapy in stroke patients. Stroke, 37, 2288–2293.
   PubMed Web of Science ®Google Scholar
• Lindgren, A., Lindoff, C., Norrving, B., Åstedt, B., & Johansson, B. B. (1996). Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients. Stroke, 27, 1066–1071.
   Google Scholar
• Margaglione, M., Di Minno, G., Grandone, E., Vecchione, G., Celentano, E., Cappucci, G., (1994) Abnormally high circulation levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with a history of ischemic stroke. Arteriosclerosis Thrombosis, 14, 1741–1745.
   PubMedGoogle Scholar
• Molina, C. A., Montaner, J., Abilleira, S., Arenillas, J. F., Ribó, M., Huertas, R., (2001). Time course of tissue plasminogen activator-induced recanalization in acute cardioembolic stroke: A case-control study. Stroke, 32, 2821–2827.
   PubMed Web of Science ®Google Scholar
• Montaner, J., Fernandez-Cadenas, I., Molina, C. A., Ribo, M., Huertas, R., Rosell, A., (2006). Poststroke C-reactive protein is a powerful prognostic tool among candidates for thrombolysis. Stroke, 37, 1205–1210.
   PubMed Web of Science ®Google Scholar
• Montaner, J., Molina, C. A., Monasterio, J., Abilleira, S., Arenillas, J. F., Ribo, M., (2003). Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. Circulation, 107, 598–603.
   PubMed Web of Science ®Google Scholar
• Nordt, T. K., Moser, M., Kohler, B., Ruef, J., Peter, K., Kubler, W., (1998). Augmented platelet aggregation as predictor of reocclusion after thrombolysis in acute myocardial infarction. Thrombosis and Haemostasis, 80, 881–886.
   PubMed Web of Science ®Google Scholar
• Ribo, M., Montaner, J., Molina, C. A., Arenillas, J. F., Santamarina, E., & Alvarez-Sabin, J. (2004). Admission fibrinolytic profile predicts clot lysis resistance in stroke patients treated with tissue plasminogen activator. Thrombosis and Haemostasis, 91, 1146–1151.
   PubMed Web of Science ®Google Scholar
• Rosell, A., Alvarez-Sabin, J., Arenillas, J. F., Rovira, A., Delgado, P., Fernandez-Cadenas, I., (2005). A matrix metalloproteinase protein array reveals a strong relation between MMP-9 and MMP-13 with diffusion-weighted image lesion increase in human stroke. Stroke, 36, 1415–1420.
   PubMed Web of Science ®Google Scholar
• Rubiera, M., Alvarez-Sabin, J., Ribo, M., Montaner, J., Santamarina, E., Arenillas, J. F., (2005). Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke. Stroke, 36, 1452–1456.
   PubMed Web of Science ®Google Scholar
• The National Institutes of Neurological Disorders and Stroke rt-PA Stroke Study Group. (1995). Tissue plasminogen activator for acute ischemic stroke. The New England Journal of Medicine, 333, 1581–1587.
   PubMedGoogle Scholar
• Wahlgren, N., Ahmed, N., Dávalos, A., Ford, G. A., Grond, M., Hacke, W., (2007). Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): An observational study. Lancet, 369, 275–282.
   PubMed Web of Science ®Google Scholar